Unitedhealth Group INC Form 4 insider transactions

NYSE
UnitedHealth Group's President and CFO, John F. Rex, disposed of 314.585 shares of common stock on November 13, 2024.
NYSE
Director Stephen J. Hemsley of UnitedHealth Group reported a gift transfer of 8,000 common shares on November 11, 2024.
NYSE
Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, sold 701 shares of common stock on November 11, 2024.
NYSE
Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.
NYSE
Director John H. Noseworthy acquired 161 shares of UnitedHealth Group common stock as part of a deferred stock unit compensation plan.
NYSE
Director Timothy Flynn reports acquisition of 161 shares of UnitedHealth Group common stock and indirect ownership of 2,000 shares via trust.
NYSE
Director Charles D. Baker reported the acquisition of 151 shares of UnitedHealth Group common stock on October 1, 2024, as part of director compensation.
NYSE
Director Michele J. Hooper reports acquiring 97 deferred stock units of UnitedHealth Group as part of regular quarterly compensation.
NYSE
Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.
NYSE
Stephen J. Hemsley, a director at UnitedHealth Group, reported acquiring 245 shares of common stock on October 1, 2024, as part of regular quarterly compensation.
NYSE
Director Frederick William McNabb III acquired 164 shares of UnitedHealth Group common stock as part of his quarterly compensation.
NYSE
Director Kristen Gil reports acquisition of UnitedHealth Group stock and deferred stock units as part of regular quarterly compensation.
NYSE
Director Valerie Montgomery Rice acquired 161 deferred stock units of UnitedHealth Group on October 1, 2024, as part of her quarterly compensation for board service.
NYSE
Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock due to dividend equivalents on restricted stock units.
NYSE
Director Michele J. Hooper reported the acquisition of 132 shares of UnitedHealth Group common stock due to dividend equivalents.
NYSE
EVP & Chief Legal Officer of UnitedHealth Group, Christopher R. Zaetta, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.
NYSE
Director Frederick William McNabb III acquired 25 shares of UnitedHealth Group common stock through dividend equivalents on vested deferred stock units.
NYSE
Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
NYSE
Director Kristen Gil reports acquisition of UnitedHealth Group common stock and dividend equivalents through direct and indirect ownership.
NYSE
Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock due to dividend equivalents.
NYSE
John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents.
NYSE
Stephen J. Hemsley, a director at UnitedHealth Group, reports acquisition of common stock and dividend equivalents.
NYSE
John H. Noseworthy, a director at UnitedHealth Group, acquired 19 shares of common stock through dividend equivalents on vested deferred stock units.
NYSE
Brian Thompson, CEO of UnitedHealthcare, reports the acquisition of common stock and dividend equivalents related to restricted stock units.
NYSE
Andrew Witty, CEO of UnitedHealth Group, reports acquisition of common stock through dividend equivalents and the Employee Stock Purchase Plan.
NYSE
Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquiring and disposing of common stock on September 24, 2024, according to a Form 4 filing with the SEC.
NYSE
Director Timothy Patrick Flynn reports acquisition of 31 shares of common stock and disposal of 2,000 shares held indirectly through a trust.
NYSE
Valerie Montgomery Rice, a director at UnitedHealth Group, acquired 20 shares of common stock through dividend equivalents on vested deferred stock units.
NYSE
Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.
NYSE
Stephen Hemsley, a director at UnitedHealth Group, reported the distribution of UNH shares from Grantor Retained Annuity Trusts and subsequent direct ownership changes.